Please complete the CAPTCHA to continue
A concise factual answer block for searchers comparing this professional profile.
Eric Gustafson is listed as Vice President, Head of Market Access at Cellectar Biosciences, Inc., based in Greater Philadelphia, United States, United States. AeroLeads shows a matched LinkedIn profile for Eric Gustafson.
Eric Gustafson previously worked as Executive Director, Head US Cell Therapy/Hematology Access Marketing at Bristol Myers Squibb and Executive Director, Head US Cell Therapy Reimbursement, Access & Value Strategy at Bristol Myers Squibb. Eric Gustafson studied at California State University, Fullerton.
This section adds company-level context without repeating Eric Gustafson's masked contact details.
Review company-level records connected to Eric Gustafson before choosing the right outreach path.
Commercial leader with 30+ years of experience spanning sales, marketing, operations, and market access, with deep expertise in navigating the complex and evolving access landscape for oncology, hematology, and rare disease brands. Proven track record in Managed Markets, Account Management, Payer and Organized Customer Strategy, Pricing and Contract Strategy, Product Lifecycle Management, and Launch Execution. Skilled at building high-performing organizations and transforming cultures to drive exceptional results and sustainable growth.As a passionate leader and strong communicator, I specialize in creating clear go-to-market strategies and messaging that drive performance. Known for my consultative leadership style, I work collaboratively across cross-functional teams—medical, legal, regulatory, marketing, and manufacturing—to achieve results.Core Competencies/Experiences as a Market Access Executive Leader: *Strategy Innovator *Talent Developer *Launch Excellence *Patient Centric *Collaborator *Organizational Shaper *Culture Transformer *Hematology/Oncology *Rare Disease *CAR T *Radiotherapy
Company context helps verify the profile and gives searchers a useful next step.
A career timeline built from the work history available for this profile.
Florham Park, New Jersey, US
Built and led the market access strategy and commercial organization from the ground up, enabling the company’s first product launch in a pre-commercial environment. Established comprehensive access capabilities, including payer strategy, pricing, reimbursement planning, distribution, and patient support programs, ensuring seamless adoption of a novel.
Lawrence Township, NJ, US
Led the expanded access strategy for a broad hematology portfolio, securing open access across all franchises and driving new indications and lifecycle management strategies.Spearheaded the access launch strategy for the expansion of a hematology product into the first-line Myelodysplastic Syndromes (MDS) setting, ensuring streamlined integration into.
Lawrence Township, NJ, US
Led a multi-functional Cell Therapy Access Team, encompassing Pricing/Contracting, Patient Access, Trade/Distribution, Policy, Access Strategy, and Account Management.Successfully developed and executed the access launch strategy for CAR T therapy in the second-line setting for Diffuse Large B-Cell Lymphoma (DLBCL), facilitating broad payer acceptance and.
Lawrence Township, NJ, US
Recruited to build account management capabilities and deploy an Account Executive team focused on organized customers.Directed a team of National Account Executives responsible for Specialty GPOs, large Hematology/Oncology accounts, and state societies.Collaborated with GPO leadership to design and execute performance-based OID/rebate contracts, driving.
Ingelheim Am Rhein, Rhineland-Palatinate, DE
Recruited to transform sales and account team culture to enhance collaboration, accountability, and business performance.Directed teams to analyze market trends, identify growth opportunities, and develop competitive strategies aligned with business goals.Delivered top 10% national sales results through strategic execution and impactful team leadership.
Directed the strategic expansion and execution of a 450-member field commercial organization, scaling the team through multiple phases to meet evolving market needs.Led the sales and account management strategy for the first PD-1 inhibitor launch in the US, setting a new standard for oncology commercialization.Consistently exceeded performance goals across.
Led the development of the commercial model structure and capabilities to support new oncology organization to launch 1st PD-1 Pathway Inhibitor in the US Market. Expanded capabilities included sales force structure, account management role, reimbursement/HUB, and data analytics platforms.Recommendations resulted in the formation of an Oncology Business.
Quick answers generated from the profile data available on this page.
Eric Gustafson works for Cellectar Biosciences, Inc..
Eric Gustafson is listed as Vice President, Head of Market Access at Cellectar Biosciences, Inc..
Eric Gustafson is based in Greater Philadelphia, United States, United States while working with Cellectar Biosciences, Inc..
Eric Gustafson has worked for Cellectar Biosciences, Inc., Bristol Myers Squibb, Boehringer Ingelheim, and Merck.
You can use AeroLeads to view verified contact signals for Eric Gustafson at Cellectar Biosciences, Inc., including work email, phone, and LinkedIn data when available.
Eric Gustafson studied at California State University, Fullerton.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial Search contacts